Bloomage BioTechnology (SHSE:688363) Total Equity: ¥7,160 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688363 Bloomage BioTechnology Corp Ltd SHSE:688363
94 GF Score
Price ¥37.55
GF Value ¥42.75
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Bloomage BioTechnology Total Equity?

Bloomage BioTechnology SHSE:688363 +3.36% 94 Total Equity is ¥7,160 Mil as of Mar. 2026. GuruFocus rates SHSE:688363 with a GF Score™ of 94/100 and a GF Value™ of ¥42.75 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Bloomage BioTechnology's total equity for the quarter that ended in Mar. 2026 was ¥7,160 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bloomage BioTechnology Total Equity Historical Data

* Premium members only.

The historical data trend for Bloomage BioTechnology's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bloomage BioTechnology Total Equity Chart

Bloomage BioTechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,702.46 6,682.99 6,983.43 6,839.80 7,115.15

Bloomage BioTechnology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,957.77 7,065.02 7,090.10 7,115.15 7,159.62
SHSE:688363
94GF Score
Bloomage BioTechnology Corp Ltd SHSE:688363
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bloomage BioTechnology Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bloomage BioTechnology's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=8692.507-1577.36
=7,115

Bloomage BioTechnology's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=8750.006-1590.382
=7,160

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ¥7,160 Mil mean?
Bloomage BioTechnology (SHSE:688363) has a Total Equity of ¥7,160 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Bloomage BioTechnology and its competitors.
Is Bloomage BioTechnology's Total Equity too high?
Bloomage BioTechnology's current Total Equity is ¥7,160 Mil. Overall, Bloomage BioTechnology has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bloomage BioTechnology's Total Equity compare to LIN and SHW?
Bloomage BioTechnology's Total Equity of ¥7,160 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Chemicals company?
A good Total Equity depends on the Chemicals industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Bloomage BioTechnology and its competitors. Bloomage BioTechnology's current Total Equity is ¥7,160 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bloomage BioTechnology stock overvalued right now?
Based on GuruFocus' analysis, Bloomage BioTechnology (SHSE:688363) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥42.75, compared to a current price of ¥37.55 — trading 12.2% below its estimated fair value. The current Total Equity is ¥7,160 Mil. Bloomage BioTechnology's overall GF Score™ is 94/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Bloomage BioTechnology (SHSE:688363), the current Total Equity is ¥7,160 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bloomage BioTechnology (SHSE:688363) Overvalued in 2026?

Based on GuruFocus' analysis, Bloomage BioTechnology stock appears to be undervalued. The current stock price of ¥37.55 is trading 12.2% below its estimated GF Value™ of ¥42.75. GuruFocus considers Bloomage BioTechnology to be Modestly Undervalued.

Key valuation signals for SHSE:688363:

  • Total Equity: ¥7,160 Mil
  • GF Value™: ¥42.75 vs. price of ¥37.55 (12.2% below fair value)
  • GF Score™: 94/100 with 8 warning signs

No single metric tells the full story. See the SHSE:688363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bloomage BioTechnology Business Description

Address No. 678, Tianchen Street, High-tech Development Zone, Shandong Province, Jinan, CHN, 250101
Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid or sodium hyaluronic acid. The company's products include raw materials, medical products, functional skincare, and functional foods. Raw materials, mainly hyaluronic acid, are used in pharmaceuticals, medical devices, cosmetics, and food. Medical products span beauty and therapeutic uses, such as viscoelastics, lubricants, fillers, and skin protectors. Skincare items include lotions, creams, and masks, while functional foods feature hyaluronic acid drinks and supplements.
94GF Score

Get the complete analysis for SHSE:688363

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥37.55
Price
¥42.75
GF Value